Author:
Gedlicka C.,Formanek M.,Selzer E.,Burian M.,Kornfehl J.,Fiebiger W.,Cartellieri M.,Marks B.,Kornek G.V.
Subject
Cancer Research,Oncology,General Medicine
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of Chemotherapy plus Cetuximab as First-line Treatment in Patients with Metastatic, Recurrent, Unresectable Head and Neck Cancers: Real-life Data;Journal of the College of Physicians and Surgeons Pakistan;2023-04-01
2. Chemotherapeutic Protocols for the Treatment of Head and Neck Cancer;Chemotherapy Protocols and Infusion Sequence;2022
3. A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer;Cancer Research and Treatment;2021-11-01
4. Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial;Medical Oncology;2021-09-22
5. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial;The Lancet Oncology;2021-04